Sigrid V. Carlsson, MD, PhD, MPH, presented “Diet, Exercise, and Lifestyle: What Do We Know?” during the 27th Annual Southwest Prostate Cancer Symposium conference on October 17, 2024, in Scottsdale, Arizona.

How to cite: Carlsson, Sigrid V. Diet, Exercise, and Lifestyle: What Do We Know?.” October 17, 2024. Accessed Jan 2026. https://grandroundsinurology.com/diet-exercise-and-lifestyle-what-do-we-know/

Diet, Exercise, and Lifestyle: What Do We Know? Summary#

Sigrid V. Carlsson, MD, PhD, MPH, delivers a 9-minute presentation exploring the influence of diet, exercise, and lifestyle on prostate health and cancer risk. Highlighting global epidemiology, she discusses significant variations in prostate cancer incidence and mortality. She underscores the modifiable and non-modifiable risk factors, emphasizing the importance of addressing diet, physical activity, and smoking cessation as key preventative strategies.

Dr. Carlsson describes the impact of physical activity in reducing risk across the disease continuum, citing promising early trials showing its benefits even before radical prostatectomy. Medications like statins, 5-alpha reductase inhibitors, and vitamin D supplementation are discussed as potential tools for reducing prostate cancer risk, while alcohol and smoking are identified as contributors to adverse outcomes. Dr. Carlsson reviews intriguing findings on factors like sexual activity, circumcision, and infections, linking them to varying levels of risk.

About the 27th Annual Southwest Prostate Cancer Symposium:
Presented by Program Chairs Nelson N. Stone, MD, Richard G. Stock, MD, and William K. Oh, MD, this conference educated attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices. It included a scientific session, as well as live demonstrations of surgical techniques. You can learn more about the conference here.

ABOUT THE AUTHOR

+ posts

Sigrid V. Carlsson, MD, PhD, MPH, is the Division Head of the Clinical Epidemiology of Early Cancer Detection at DKFZ German Cancer Research Center in Heidelberg, Germany. Her research focuses on developing risk-stratified approaches to screening, diagnosis, treatment, and follow-up.